《美股业绩》路透母公司汤森路透季绩胜预期 出售Refinitiv录重大收益
《路透》母公司汤森路透(Thomson Reuters)(TRI.US)公布首季业绩。季度纯利50.36亿美元,按年升25倍。每股季度摊薄纯利10.13美元,经调整後为每股58美仙,高於市场预期的42美仙。季度收入15.8亿美元,按年升3.9%。
公司向伦敦证券交易所出售Refinitiv录得重大收益,期内证券投资税前溢利62.97亿美元,对上年度同期录5,400万美元亏损。公司目前持有伦敦证券交易所15%股权。
公司预期现季度收入按年升5.5%至6.5%,全年收入料增长3.5%至4%,早前预测为增长3%至4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.